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Lungworm in Cattle: Treatment and Control 
Andrew Forbes. Scottish Centre for Production Animal Health and Food Safety, School of Veterinary 
Medicine, University of Glasgow, G61 1QH  
Abstract 
Treatment options for clinical parasitic bronchitis (PB) are largely based on anthelmintics, with 
supportive therapy including non-steroidal anti-inflammatories (NSAIDs) and antibiotics, when 
indicated. Macrocyclic lactones (MLs), benzimidazoles and levamisole are all effective against adult 
and larval lungworms, so the choice of product depends on other criteria, including duration of 
action and ease of administration, which can be important in dyspnoeic animals. Control of PB in 
youngstock can be accomplished through the use of anthelmintics in early-season strategies 
designed to limit pasture D. viviparus larval populations, but are not easy to implement in herds 
other than on autumn-calving dairy farms. Likewise, though vaccination provides predictable control 
of PB in youngstock, it is best suited to calves from autumn calving herds, however, it can also be 
used pre-turnout as a ‘booster’ in previously exposed, older cattle. Grazing management has a 
limited role to play in the control of PB both because of unreliability and because some of the 
recommendations run counter to recommended grassland management practices. Veterinary 
clinicians need to familiarise themselves with all possible options and outcomes for the control of PB 
and tailor their recommendations to the individual farm and farmer.  
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Introduction 
Parasitic bronchitis (PB) or verminous pneumonia in cattle results from infection with the lungworm 
Dictyocaulus viviparus. The outcomes of infection range from mortality through clinical and 
subclinical disease and production losses to carrier animals, which are important epidemiologically, 
but in which adverse effects are minimal.  The need for prompt, effective treatment of clinical cases 
and long term control of infection are self-evident. The various options available to large animal 
clinicians in the treatment and control of PB are examined critically in this paper, which follows on 
from a companion article in this journal on the epidemiology, pathology and immunobiology of 
lungworm in cattle. As with its predecessor, this article aims to complement and extend the review 
article previously published in Livestock (Tilling, 2014). 
Treatment of Clinical Cases 
All of the principle groups of anthelmintics licensed in cattle are effective against adult and larval D. 
viviparus; hence there is a wide choice of actives and formulations that can be used to treat clinical 
cases of lungworm. The optimal treatment approach to severe clinical cases of husk needs to be 
based on criteria other than just efficacy however because some patients will be in a critical state in 
which even handling could precipitate a potentially fatal deterioration in their condition. In such 
cases, there is a strong argument to use injectable or topical products as opposed to oral drenches.  
The relative importance of speed and mode of action in treatment responses in PB is unknown, 
though this does not stop quite widespread opinions being held on the merits or otherwise of 
various products (Tilling, 2014). Table 1 shows the comparative speed and mode of action of 
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fenbendazole and levamisole (Oakley, 1980). Also included in the table is an estimate for macrocyclic 
lactones (MLs), but their speed of action against D. viviparus has not been specifically measured. 
Evidence from clinical (Taylor et al., 1990) and parasitological (Eysker et al., 1996) studies indicate 
that MLs act at a rate similar the benzimidazoles.  
Although both benzimidazoles and levamisole seem to be equally effective in treating clinical cases 
(Downey, 1980), there are reports, based on studies conducted in the 70s and 80s (Table 2), of 
different mortality rates in calves following treatment (Jarrett et al., 1980; McEwan et al., 1979). 
Some of the histopathology described in these cases is identical to what has been observed in fatal 
cases of PB in animals that had not been treated (Jarrett et al., 1954, 1957b). No specific studies on 
MLs have been conducted, though there is a description of similar histopathology in two calves that 
failed to respond to treatment with an ML (SAC, 2014), however it has also been reported that the 
incidence of such lesions has become less common since the introduction of the MLs (Taylor et al., 
1997). The overall conclusion from this limited evidence base is that histopathological changes are 
present in the lungs of animals that die of PB, whether treated with anthelmintics or not, though 
there is some evidence for higher mortality following fenbendazole treatment.  
The possibility that the clinical signs of husk can be exacerbated by anthelmintic treatment has been 
documented in observations on animals treated with diethylcarbamazine (Jarrett et al., 1962), 
fenbendazole or levamisole and the propensity of either one of the last two drugs to elicit such 
responses has been the subject of some debate  (Jarrett et al., 1980; McEwan et al., 1979; Oakley, 
1980, 1981; Urquhart, 1981).  One of the arguments put forward is that, because the action of 
levamisole is to paralyse worms, they are removed rapidly from the lungs without degenerating in 
situ, thereby reducing any associated inflammatory changes in the airways that may result from the 
release of bioactive compounds from degenerating worms (Oakley, 1981). In treatment of severe 
clinical cases of PB, there is no objective evidence for any differences in sequelae between 
levamisole and MLs, both of which act by paralysing susceptible parasites,  and the rationale (speed 
and mode of action) proposed by some who speculate on such differences (Tilling, 2014) does not 
stand up to scientific scrutiny (Pouplard et al., 1986; Taylor et al., 1990). Cattle with heavy lungworm 
burdens and severe clinical signs must be treated with an anthelmintic or they may die of 
overwhelming infection, but farmers should be warned that in a few cases, exacerbation of clinical 
signs may follow treatment (irrespective of which product is used) and such cases need supportive 
treatment. Given the importance of host responses in the pathophysiology of husk, it would be 
prudent to include treatment with anti-inflammatory drugs in severe or non-responding cases. 
Equally, in adult cattle, which may be showing clinical signs related to the re-infection syndrome, the 
use of non-steroidal anti-inflammatory drugs (NSAIDs) to counter the immunopathology, would 
seem to be indicated.  
A further consideration in therapy is the persistent activity of anthelmintics, which is an important 
criterion if treated animals are to be kept in the field where they acquired infection and/or when low 
risk pastures or premises are not available. All the MLs possess persistent activity against D. 
viviparus, but neither fenbendazole drench, not levamisole do; essentially they are effective for ~24 
hours against worms that are present at the time of treatment, but offer no protection against 
subsequent (pasture) challenge.  The value of persistency in the protection of cattle following 
treatment was demonstrated in a study in which clinical cure rates were good and equivalent one 
week after treatment, when lungworm numbers in the lungs were reduced by 100% and 93% for 
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ivermectin (injection or topical) and levamisole respectively (Figure 1). However, when treated 
animals were challenged 14 days after treatment, the ivermectin-treated animals remained free of 
parasites, whereas calves treated with levamisole showed clinical signs and developed patent 
lungworm infections (Taylor et al., 1990) due to limited immunity and a lack of anthelmintic activity.  
Control of PB in young stock 
 Pasture management 
Delayed turnout 
There is some evidence from Denmark and the United Kingdom (UK) that over-winter larval survival 
on pasture declines markedly in late April and May and that late turnout of calves can result in 
avoidance of lungworm challenge and, through lack of auto-infection, low pasture D. viviparus larval 
populations over the remainder of the grazing season (Jacobs and Fox, 1985; Jorgensen, 1980). 
Whilst adoption of this practice is likely to be limited on grassland farms, where optimal grazing of 
high quality spring grass is widely recommended (Frame and Laidlaw, 2011), from a parasitological 
point of view, control of both lungworm and parasitic gastroenteritis in young calves can be 
achieved using late turnout (Nansen et al., 1987). 
Rotational grazing 
Though there are reports of successful control of husk using weekly paddock rotations (Eysker et al., 
1992), this is likely to be impractical on many commercial farms and furthermore in these studies, 
pasture rotation was found to be ineffective in the simultaneous control of PGE.  
Dose-and-Move 
Several studies have shown that ‘dose-and-move’ can be effective in the control of lungworm 
(Eysker et al., 1996; Eysker et al., 1997), though adequate control of husk was not achieved on 
several farms in a larger scale study (Eysker et al., 1997). Mitigation of potential increased risks of 
selection for anthelmintic resistance through this practice have been addressed elsewhere (Forbes, 
2017), though this aspect is of more relevance to PGE than PB. 
Vaccination 
 A vaccination approach to the control of PB, researched in Glasgow in the 1950s (Jarrett et al., 
1957a), was based on irradiated infective D. viviparus larvae. Following  further development by 
Allen & Hanburys Ltd, Ware, Herts, a commercial vaccine was launched in February 1959 under the 
trade name ‘Dictol’ (Poynter et al., 1960). The vaccine is currently available under the trade name 
Bovilis® Huskvac (MSD Animal Health); it is categorised as a POM-V product. Each 25 ml dose of 
vaccine comprises 1000-2000 irradiated, viable infective larvae (L3) of D. viviparus. The 
recommended schedule is to vaccinate calves ≥8 weeks of age with two doses, administered four 
weeks apart; animals should not be turned out onto pasture until 2 weeks after the second 
vaccination. If indicated, cattle can be given a single dose of vaccine as a ‘booster’ before turnout in 
subsequent years (NOAH, 2015). The shelf-life is 90 days and vaccine is typically supplied early in the 
year in order that eligible calves can complete the course of vaccination before turnout.  
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For optimal protection, it is recommended that vaccinated animals are exposed to low-grade 
exposure of D. viviparus in order that the Phase 1 immune response is maintained. Whilst this advice 
is useful, it is in fact very difficult to manage at farm level because of the inherent variability in 
lungworm epidemiology and the possible confounding effects of concurrent measures to control 
PGE, for example anthelmintic use and pasture management. Nonetheless, under commercial 
farming conditions, good control of PB would be expected over the grazing season following 
vaccination pre-turnout, though some vaccinated animals will develop patent infections and 
immune protection may be overwhelmed by high challenge (Downey, 1965). It should also be 
remembered that vaccinated animals can become carriers and initiate outbreaks of PB in naïve 
calves (Cornwell and Berry, 1960), thus mixing vaccinated and unvaccinated calves is not 
recommended, nor should the vaccine be used in herds where D. viviparus is not present. 
Given the guidance for use of the vaccine, it is evident that there are some practical and logistical 
limitations on its use. It fits optimally into an autumn calving dairy herd, where calves should be of 
the right age to complete the vaccination course prior to turnout, however, these conditions are not 
met in spring-calving herds and, although vaccination at pasture, vaccination of animals less than 8-
weeks of age and shortened intervals between doses have all been trialled (Benitez Usher et al., 
1976; Downey, 1968, 1984), these practices are not always successful and are not data-sheet 
recommendations. Equally, with the exception of dedicated spring-calving herds, most dairy farms in 
the UK calve cows all year-round (Gates, 2013), hence at any one time, only a proportion of the 
annual calf crop is eligible to participate in the vaccination protocol. Finally, there is a cost element, 
which needs to be factored in to discussions of nematode control, particularly in FGS calves. 
Currently the ratio between the ex-distributor (www.farmacy.co.uk) cost of a course of lungworm 
vaccination (2 doses) and the cost of two (250 kg) doses with a generic ML pour-on is around 20:1, 
so a value judgement is needed to determine the optimal course, taking into consideration the likely 
need for concurrent PGE control. 
 Anthelmintics 
Strategic 
The control of PB through the strategic use of anthelmintics has been well documented (David, 
1999); the majority of these strategies are based on anthelmintic administration to FGS weaned 
calves at or within three weeks of turnout, with coverage extending until at least mid-July. Adoption 
of these practices was facilitated by the introduction of the ML anthelmintics, which have persistent 
activity against D. viviparus (Armour et al., 1987) and which provided better control of PB than short 
acting products (Jacobs et al., 1985). Long-lasting anthelmintic boluses and injections also greatly 
simplify the implementation of strategic programmes as only single treatments are required to 
provide the required coverage (Jacobs et al., 1986).  
The principles behind this approach are essentially those used in the control of PGE, which is to treat 
animals in a schedule that minimises/limits the contamination of pasture with worm eggs or larvae, 
thus treatment intervals are a function of the pre-patent period and the duration of persistent 
efficacy (if any) against the target parasites. The first treatment must be given within 3 weeks (the 
pre-patent period) after turnout to eliminate the first generation of gravid female worms; however, 
for convenience many farmers elect to administer treatments at turnout. Topical MLs, all of which 
have persistent activity claims of 4-6 weeks against D. viviparus, can be used in regimes using two or 
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three treatments at 5-8 week intervals. Equivalent (or greater) coverage can be achieved using 
moxidectin 10% long-acting injection (120 days persistency against D. viviparus) or benzimidazole 
intra-ruminal boluses (105-147 days). As strategic treatments are designed to minimise 
contamination of the pasture in which the cattle are kept, treated cattle should be kept in the same 
field throughout the grazing season. If cattle are moved to different pastures on which untreated 
cattle have grazed, they may be at risk of PB again, particularly if anthelmintic activity has ceased by 
then.  
Anthelmintic treatment of cattle at housing can also be considered as strategic, as it can remove not 
only adult and larval worms, but also inhibited Dictyocaulus viviparus larvae, which are important in 
carrier animals and the perpetuation of infection from one grazing season to another. In regions 
where over-winter survival of Dictyocaulus viviparus on pasture is minimal, elimination of lungworm 
from farms for several years can be achieved through anthelmintic treatment of cattle during the 
winter housing period (Ploeger and Holzhauer, 2012).  
Targeted selective treatment (TST) 
In the control of PGE, the concept of treating only individuals that would benefit most from 
anthelmintic treatment is becoming established as an approach that can mitigate the potential risk 
not only of anthelmintic resistance (Kenyon et al., 2013), but also environmental impact (Cooke et 
al., 2017), by enhancing the size of the refugia. Amongst domestic ruminants, most work on TST has 
been conducted in youngstock and the most promising marker is not in fact a parasitological 
measure, but daily live weight gain (Busin et al., 2014; Jackson et al., 2017), which has been shown 
to be a good surrogate for adverse effects of PGE in both lambs and young cattle. In terms of animal 
performance and resistance management, modelling studies have also shown that live weight gain is 
a superior marker as a determinant for TST in young cattle (Berk et al., 2016) and lambs (Laurenson 
et al., 2016) compared to parasitological measurements.  
There has been much less work on the use of TST in controlling PB. In one study designed to 
evaluate TST in the control of both PGE and PB, faecal samples were collected at 3-weekly intervals 
and examined for lungworm larvae using the Baermann technique; calves were treated if positive 
(O'Shaughnessy et al., 2015). Despite this sampling and treatment schedule, hoose was inadequately 
controlled and ~20% of the animals had to be removed from the study on welfare grounds, mostly 
because of dictyocaulosis. The authors proposed that vaccination should be used to control 
lungworm, where it is endemic, before attempting to employ TST for the control of PGE, to avoid the 
disruptive effects of hoose.  
Another approach, which was adopted on a Swedish organic farm, was to treat individual animals on 
the basis of seropositivity to D. viviparus (Hoglund, 2006).  Sampling was carried out at monthly 
intervals in the wake of outbreaks of disease and twice a year otherwise over a period of three 
years. Generally control of lungworm infection was good under this regime, however clinical PB did 
occur in August and September of the second year, but affected animals responded well to 
treatment with ivermectin injection. Given the sampling frequency and the cost of collecting and 
processing the samples, it seems unlikely that this approach would be readily adopted by 
commercial farmers currently. 
Reflections on current options for the control of parasitic bronchitis 
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 It is useful to remember that the ‘classical’ measures to control PB: vaccination and/or strategic 
anthelmintics were researched and developed in FGS, weaned calves from autumn/winter-calving 
dairy herds. As strictly seasonal autumn-calving dairy herds now comprise a small percentage of the 
national herd (Gates, 2013), a rethink of how control of PB (and PGE) is best managed in youngstock 
under other systems is long overdue.   
 Spring calving herds 
FGS calves from spring-calving herds, whether dairy or beef, are not good candidates for either 
vaccination or strategic anthelmintic programmes: different approaches are needed. 
Spring-born beef suckler (cow-calf) systems 
Pre-weaning, it is unusual for suckler calves to suffer clinical parasitism, though small production 
losses can occur (Forbes et al., 2002). Lungworm is most likely to occur between weaning and 
housing if calves are grazed on infected pastures. Given that their immune status is largely unknown 
at this time, it is safest to assume that they are naïve and therefore susceptible to PB, so unless the 
risk status of the pastures they will graze can be confidently predicted, it may be prudent to treat all 
calves with an injectable or topical anthelmintic with persistent activity to provide coverage up to 
housing. If housing occurs within the period of persistency, then a housing dose (for PB & PGE) may 
be unnecessary. 
Before the start of the second grazing season, vaccination can be considered, particularly for 
replacement heifers that are destined to stay within a herd where dictyocaulosis is endemic. For 
steers that are to be marketed before two years of age, strategic anthelmintic regimes can make 
sense, though the schedules can be relaxed slightly (Taylor et al., 1995), on the assumption that 
some exposure and naturally acquired immunity to PB (and PGE) has occurred during the FGS. As a 
general rule, it is recommended to keep vaccinated and unvaccinated stock apart (Cornwell and 
Berry, 1960), so this needs to be considered if different regimens are used in steers and heifers. 
Routine anthelmintic treatments for PB should not be required for adult cattle, other than at 
housing, and vaccination would only be indicated in herds with high levels of PB. Otherwise, control 
of dictyocaulosis is based on vigilance and prompt treatment (Michel, 1969) whenever infection or 
clinical signs are detected. Indeed, on farms or in groups of cattle where no vaccination or 
preventative anthelmintic treatments are undertaken, then vigilance and treatment remains the 
best option, irrespective of the system. 
Spring-calving dairy herds 
On grass-dependent, spring-calving dairy farms, calves are frequently put out to grass from an early 
age, sometimes before weaning off milk-replacement. For convenience, paddocks close to the 
steading and calving area are used for the calves and this is therefore quite likely to be in the same 
location each year, with a potential risk of infection carrying over. However, because such paddocks 
may only be grazed by calves for a few months in spring each year, there is the opportunity to 
manage them for the remainder of the grazing season in a way that limits infectivity, such as 
shutting them up for silage. Grazing with adult cows is also an option, but the risk of contamination 
of calf paddocks with infective larvae of D. viviparus (and Ostertagia ostertagi) is quite high. Moving 
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FGS calves onto recently cut silage fields can provide relatively clean grazing and anthelmintic 
treatment at this time may be justified to help control PB (Eysker et al., 1996; Forbes, 2017). 
As for SGS beef calves, the options for PB control in yearlings/heifers include vaccination and 
strategic anthelmintics with the option of vigilance and treatment if no preventative actions are 
taken. Booster vaccination before turnout should be considered for milking cows in herds that have 
experienced several episodes of PB and/or the re-infection syndrome in adult animals. In such herds, 
housing treatments for lungworm could also be included to eliminate infection in carrier animals. 
Irrespective of preventative measures, during the grazing season, vigilance and treatment is the 
order of the day. If disease levels are unacceptable, then a review of grazing practices may be 
required as high frequency rotations with high stocking rates may result in levels of challenge that 
can overwhelm vaccination and/or medication. 
All-year-round (AYR) calving dairy herds 
There are self-evident logistical problems in managing parasites in AYR herds as at any one time 
there will be calves ranging between a few days old and 12 months of age on the farm. Probably the 
most pragmatic approach is to divide calves into a limited number of cohorts and manage them as 
separate units. For example, all calves born in autumn and winter could comprise a cohort and these 
would be appropriate candidates for vaccination and/or strategic anthelmintic medication. Calves 
born in the spring and summer may be managed as one or two cohorts, depending on how they will 
be managed post-weaning, in particular whether they will graze and where. From July onwards, high 
levels of larval challenge can be expected on fields where untreated cattle have grazed from turnout. 
Unless there is adequate anthelmintic protection in place, it would be best if young calves were not 
mixed with cattle that have grazed since turnout, nor should they have access to fields on which 
older cattle have previously grazed.  
Management of bulling heifers and young cattle from 12 to 24 months of age up to first calving will 
again depend on their month of birth and how much exposure to parasites they have experienced in 
their first 12 months of life. Control of PB (and PGE) in second year animals can be loosely based on 
the approach used in calves, though it may be possible to run them in larger cohorts and vaccination 
of all older animals before turnout becomes a viable option. In the milking herd, preventative 
measures include a booster vaccination before turnout, if the impact of dictyocaulosis warrants it, 
and anthelmintic treatment at housing to remove lungworm burdens from all cattle, including 
potential carriers. During the grazing season, under most circumstances, vigilance and treat is the 
mantra. 
  
Closing remarks 
Husk is a fascinating, but at the same time, frustrating disease: fascinating because of the many 
intriguing aspects of the biology of the parasite; frustrating because of its idiosyncrasies, which can 
make diagnosis challenging, treatment responses unpredictable and control difficult. Although good 
control of PB in youngstock is achievable, there remain many unanswered questions regarding 
dictyocaulosis in the dairy herd. For example in herds where the same groups of cattle can 
experience several clinical episodes during a single grazing season, despite the fact that they would 
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be expected to have acquired a protective immune response following initial exposure. Depending 
on herd demographics, it is quite possible that there may be animals within the same group 
experiencing a primary lungworm infection and others that are suffering from the re-infection 
syndrome. Booster vaccination could provide a means to equalise the immune status of a herd 
before turnout, but cost, convenience and culture can be significant barriers. Because of the 
potential fatal outcomes to infection in milking cows and the financial penalties that can arise 
through loss of milk yield and treatment costs (Holzhauer et al., 2011), many farmers are 
understandably averse to risk taking and may elect to treat entire groups or herds with anthelmintic 
– on several occasions. This practice may in itself lead to some level of enzootic instability, as 
primary infections that are treated at an early stage may not induce a full protective immune 
response (Hoglund et al., 2003). Whilst this scenario is highly speculative (McLeonard and Van Dyk, 
2017), it does highlight the conundrum facing dairy farmers and their veterinary surgeons, who face 
a proverbial ‘Catch 22’ dilemma in deciding what are optimal practices for vaccination, anthelmintic 
use and grazing management to control lungworm on a farm-by-farm basis. 
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Key points 
 Anthelmintic treatment of clinical cases of lungworm needs to be assessed carefully, 
particularly if animals are in respiratory distress 
 Apparent treatment failures may be due to irreversible lung pathology 
 Control of parasitic bronchitis through vaccination and/or strategic use of anthelmintics is 
logistically difficult in calves other than those derived from autumn calving herds. 
 In the absence of preventative measures, the management of lungworm depends on 
constant vigilance and prompt treatment when indicated 
 Grazing management is of limited value in the control of parasitic bronchitis and some of the 
recommendations contradict those for optimal grassland and grazing management 
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Tables 
 
1. Summary information on anthelmintics than can be used to treat clinical cases of parasitic 
bronchitis (NOAH, 2015; Oakley, 1980). 
 
2. Potential outcomes and lung pathology in treated and untreated cases of dictyocaulosis 
(Jarrett et al., 1954; McEwan et al., 1979). 
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1. Comparative efficacy of topical formulations of ivermectin and levamisole against induced 
lungworm infections (Taylor et al., 1990). 
 
 
